{"id":3286,"date":"2017-10-27T15:53:25","date_gmt":"2017-10-27T19:53:25","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=3286"},"modified":"2017-10-27T15:53:25","modified_gmt":"2017-10-27T19:53:25","slug":"new-filings-updated-terms-week-ending-10-27-17","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/new-filings-updated-terms-week-ending-10-27-17\/","title":{"rendered":"New Filings & Updated Terms (Week Ending 10.27.17)"},"content":{"rendered":"


\n<\/a>IPO Boutique keeps apprised of the active pipeline. Currently there are 81 active IPOs in the pipeline as of October 27, 2017. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why \u201clooks may be perceiving\u201d when it comes to the IPO pipeline\u00a0in this article.<\/strong><\/a><\/p>\n

\"Pipeline10.27.17\"<\/a><\/p>\n

NEW FILINGS<\/strong><\/p>\n

Company: iClick Interactive Asia Group Limited
\nSymbol: ICLK
\nDescription: They were the largest independent online marketing technology platform in China in terms of gross billing in 2016 according to Frost & Sullivan.
\nTrade Date: TBD
\nUnderwriter(s): Credit Suisse, Nomura
\nFiled 10-20-17
\nListed Cash Raise: $100 million<\/p>\n

Company: SailPoint Technologies Holdings, Inc.
\nSymbol: SAIL
\nDescription: SailPoint is the leading provider of enterprise identity governance solutions.
\nTrade Date: TBD
\nUnderwriter(s): Morgan Stanley, Citigroup, Jefferies, RBC Capital Markets
\nCo-Manager(s): KeyBanc Capital, Canaccord Genuity, Oppenheimer & Co.
\nFiled 10-20-17
\nListed Cash Raise: $100 million<\/p>\n

Company: Arsanis, Inc.
\nSymbol: ASNS
\nDescription: They are a clinical-stage biopharmaceutical company focused on applying monoclonal antibody immunotherapies to address serious infectious diseases.
\nTrade Date: TBD
\nUnderwriter(s): Citigroup, Cowen, Piper Jaffray
\nFiled 10-20-17
\nListed Cash Raise: $57.5 million<\/p>\n

Company: Jianpu Technology Inc.
\nSymbol: TBD
\nDescription: They are the leading independent open platform for discovery and recommendation of financial products in China, whether measured by the number of loan applications or by the number of credit card applications over the period from 2012 to 2016, according to a report that we commissioned from iResearch, which we refer to as the iResearch Report.
\nTrade Date: TBD
\nUnderwriter(s): Goldman Sachs (Asia), Morgan Stanley, J.P. Morgan
\nCo-Manager(s): China Renaissance
\nFiled 10-20-17
\nListed Cash Raise: $200 million<\/p>\n

Company: Bluegreen Vacations Corporation
\nSymbol: BXG
\nDescription: They are a leading vacation ownership company that markets and sells vacation ownership interests and manages resorts in top leisure and urban destinations.
\nTrade Date: TBD
\nUnderwriter(s): Stifel, Credit Suisse
\nCo-Manager(s): BofA Merrill Lynch, SunTrust Robinson Humphrey
\nFiled 10-23-17
\nListed Cash Raise: $100 million<\/p>\n

Company: scPharmaceuticals, Inc.
\nSymbol: SCPH
\nDescription: They are a pharmaceutical company focused on developing and commercializing products that have the potential to transform the way therapy is delivered, advance patient care and reduce healthcare costs.
\nTrade Date: TBD
\nUnderwriter(s): Jefferies, Leerink, BMO Capital Markets
\nFiled 10-23-17
\nListed Cash Raise: $100 million<\/p>\n

Company: Newmark Group, Inc.
\nSymbol: NMRK
\nDescription: Newmark is a rapidly growing, high margin, full-service commercial real estate services business that offers a full suite of services and products for both owners and occupiers across the entire commercial real estate industry.
\nTrade Date: TBD
\nUnderwriter(s): Goldman Sachs & Co., BofA Merrill Lynch, Citigroup, Cantor Fitzgerald
\nFiled 10-23-17
\nListed Cash Raise: $100 million<\/p>\n

Company: CURO Group Holdings Corp.
\nSymbol: CURO
\nDescription: They are a growth-oriented, technology-enabled, highly-diversified consumer finance company serving a wide range of underbanked consumers in the United States, Canada and the United Kingdom and are a market leader in our industry based on revenues.
\nTrade Date: TBD
\nUnderwriter(s): Credit Suisse, Jefferies, Stephens Inc.
\nCo-Manager(s): William Blair, Janney Montgomery Scott
\nFiled 10-24-17
\nListed Cash Raise: $100 million<\/p>\n

Company: Insurance Income Strategies Ltd.
\nSymbol: ILS
\nDescription: They are a newly incorporated Bermuda holding company seeking to offer collateralized reinsurance in the property catastrophe market.
\nTrade Date: TBD
\nUnderwriter(s): Joseph Gunnar & Co.
\nFiled 10-24-17
\nListed Cash Raise: $57.5 million<\/p>\n

Terms Added:<\/strong><\/p>\n

Company: Aquantia Corp.
\nSymbol: AQ
\nDescription: They are a leader in the design, development and marketing of advanced high-speed communications integrated circuits, or ICs, for Ethernet connectivity in the data center, enterprise infrastructure and access markets.
\nShares: 6.8 million
\nPrice Range: $10.00-$12.00
\nTrade Date: 11\/3
\nUnderwriter(s): Morgan Stanley, Barclays, Deutsche Bank Securities
\nCo-Manager(s): Needham & Co., Raymond James
\nTerms Added: 10-23-17<\/p>\n

Company: Funko, Inc
\nSymbol: FNKO
\nDescription: They are a leading pop culture consumer products company.
\nShares: 13.3 million
\nPrice Range: $14.00-$16.00
\nTrade Date: 11\/2
\nUnderwriter(s): Goldman Sachs & Co., J.P. Morgan, BofA Merrill Lynch
\nCo-Manager(s): Piper Jaffray, Jefferies, Stifel, BMO Capital Markets, SunTrust Robinson Humphrey
\nTerms Added: 10-23-17<\/p>\n

Company: Allena Pharmaceuticals, Inc.
\nSymbol: ALNA
\nDescription: They are a late-stage clinical biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders.
\nShares: 5.3 million
\nPrice Range: $14.00-$16.00
\nTrade Date: 11\/2
\nUnderwriter(s): Credit Suisse, Jefferies, Cowen & Company
\nCo-Manager(s): Wedbush PacGrow
\nTerms Added: 10-23-17<\/p>\n

Company: Spero Therapeutics, Inc.
\nSymbol: SPRO
\nDescription: They are a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multi-drug resistant bacterial infections.
\nShares: 5 million
\nPrice Range: $14.00-$16.00
\nTrade Date: 11\/2
\nUnderwriter(s): BofA Merrill Lynch, Cowen & Company, Stifel
\nCo-Manager(s): Oppenheimer & Co.
\nTerms Added: 10-23-17<\/p>\n","protected":false},"excerpt":{"rendered":"

IPO Boutique keeps apprised of the active pipeline. Currently there are 81 active IPOs in the pipeline as of October 27, 2017. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why \u201clooks may be perceiving\u201d when it comes to the IPO pipeline\u00a0in this article. NEW FILINGS Company: iClick[…]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24],"tags":[],"class_list":["post-3286","post","type-post","status-publish","format-standard","hentry","category-ipo"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3286","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=3286"}],"version-history":[{"count":2,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3286\/revisions"}],"predecessor-version":[{"id":3289,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3286\/revisions\/3289"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=3286"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=3286"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=3286"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}